149
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3η protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis

, , ORCID Icon, , , , , , , , & show all
Pages 67-71 | Received 26 Jun 2020, Accepted 11 Aug 2020, Published online: 07 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Wendong Xie, Hua Yang, Chun Guo, Rui Xie, Guoliang Yu & Yifu Li. (2023) Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis. Drug Design, Development and Therapy 17, pages 691-706.
Read now
Liming Tan, Tanglin Ouyang, Xu Li, Yinyi Chen, Shipeng Ke, Jiayuan Chen, Ye Liu, Fajun Zeng, Yingxing Chen, Jing Long, Qingyue Deng & Xiaoyan Hu. (2023) Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis. Autoimmunity 56:1.
Read now
D Abdelhafiz, T Baker, DA Glascow & Ah Abdelhafiz. (2023) Biomarkers for the diagnosis and treatment of rheumatoid arthritis – a systematic review. Postgraduate Medicine 135:3, pages 214-223.
Read now
Eman Mostafa Nassef, Hemmat Ahmed Elabd, Hala Mohamed Elzomor, Basma Mohamed Mohamed Ali El Nagger, Amira Shahin Ibrahim, Amal Hussein Ibrahim, Hend Gamal Kotb, Donia Ahmed Hassan, Rasha Elsayed Mohamed Abd ElAziz & Eman El Sayed Mohamed. (2022) Serum Collagen Triple Helix Repeat Containing-1 Levels are Related to Radiological Affection and Disease Activity in Rheumatoid Arthritis. Open Access Rheumatology: Research and Reviews 14, pages 291-299.
Read now
G Orchard, A Rhodes & NW Brown. (2021) British Journal of Biomedical Science in 2021. What have we learned?. British Journal of Biomedical Science 78:4, pages 159-166.
Read now

Articles from other publishers (5)

Reem El-Mallah, Dina A. Farrag & Nesma Ahmed Safwat. (2023) Potential value of collagen triple helix repeat containing-1 (CTHRC1) in systemic lupus erythematosus (SLE) patients with arthritis detected clinically or by musculoskeletal ultrasound. The Egyptian Rheumatologist 45:3, pages 197-202.
Crossref
Bruno Bohn, Pamela L. Lutsey, Weihong Tang, James S. Pankow, Faye L. Norby, Bing Yu, Christie M. Ballantyne, Eric A. Whitsel, Kunihiro Matsushita & Ryan T. Demmer. (2023) A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. Journal of Proteomics 272, pages 104788.
Crossref
Noha H. Ibrahim, Nashwa I. Hashaad, Noha M. Abdelnaser, Maha H. Morsi, Iman M. Fawzy, Rasha Abdel Hameed & Shaza A. Abdul Basset. (2023) Collagen triple-helix repeat containing 1 (CTHRC1) protein in rheumatoid arthritis patients: Relation to disease clinical, radiographic and ultrasound scores. The Egyptian Rheumatologist 45:1, pages 87-91.
Crossref
Zahraa I. Selim, Rania M. Gamal, Lobna A Araby, Eman R. Badawy & Nada M. Gamal. (2022) Collagen triple helix repeat containing 1 (CTHRC1) protein: A promising biomarker for evaluation of rheumatoid arthritis patients. The Egyptian Rheumatologist 44:1, pages 11-14.
Crossref
Askhat Myngbay, Limara Manarbek, Steve Ludbrook & Jeannette Kunz. (2021) The Role of Collagen Triple Helix Repeat-Containing 1 Protein (CTHRC1) in Rheumatoid Arthritis. International Journal of Molecular Sciences 22:5, pages 2426.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.